DexCom, Inc. (DXCM) capitalization

Current snapshot

Market Cap
$24.14B
384.8M shares × $61.90
Net Worth
$2.75B
Stockholders' equity · 2025-12-31
Enterprise Value
$23.38B
Market cap + debt − cash
Net Debt
-$762.2M
Debt $155.5M − Cash $917.7M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $26.91B
FY'24 2024-12-31 $32.10B
FY'23 2023-12-31 $52.80B
FY'22 2022-12-31 $48.41B
FY'21 2021-12-31 $57.56B
FY'20 2020-12-31 $38.86B
FY'19 2019-12-31 $20.19B
FY'18 2018-12-31 $10.57B
FY'17 2017-12-31 $4.95B
FY'16 2016-12-31 $5.05B
FY'15 2015-12-31 $6.69B
FY'14 2014-12-31 $4.26B
FY'13 2013-12-31 $2.57B
FY'12 2012-12-31 $944.5M
FY'11 2011-12-31 $628.4M
FY'11 2011-03-31

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q4'25 2025-12-31 $25.54B
Q3'25 2025-09-30 $27.41B
Q2'25 2025-06-30 $35.63B
Q1'25 2025-03-31 $27.83B
Q4'24 2024-12-31 $30.38B
Q3'24 2024-09-30 $27.50B
Q2'24 2024-06-30 $47.26B
Q1'24 2024-03-31 $57.80B
Q4'23 2023-12-31 $47.82B
Q3'23 2023-09-30 $39.82B
Q2'23 2023-06-30 $55.45B
Q1'23 2023-03-31 $48.62B
Q4'22 2022-12-31 $43.74B
Q3'22 2022-09-30 $34.29B
Q2'22 2022-06-30 $31.41B
Q1'22 2022-03-31 $54.83B
Q4'21 2021-12-31 $52.08B
Q3'21 2021-09-30 $58.83B
Q2'21 2021-06-30 $45.59B
Q1'21 2021-03-31 $37.59B
Q4'20 2020-12-31 $35.53B
Q3'20 2020-09-30 $41.02B
Q2'20 2020-06-30 $39.32B
Q1'20 2020-03-31 $25.34B
Q4'19 2019-12-31 $20.04B
Q3'19 2019-09-30 $13.80B
Q2'19 2019-06-30 $13.65B
Q1'19 2019-03-31 $10.75B
Q4'18 2018-12-31 $10.78B
Q3'18 2018-09-30 $12.92B
Q2'18 2018-06-30 $8.49B
Q1'18 2018-03-31 $6.53B
Q4'17 2017-12-31 $4.99B
Q3'17 2017-09-30 $4.24B
Q2'17 2017-06-30 $6.39B
Q1'17 2017-03-31 $7.31B
Q4'16 2016-12-31 $5.05B
Q3'16 2016-09-30 $7.41B
Q2'16 2016-06-30 $6.63B
Q1'16 2016-03-31 $5.58B
Q4'15 2015-12-31 $6.69B
Q3'15 2015-09-30 $6.91B
Q2'15 2015-06-30 $6.37B
Q1'15 2015-03-31 $4.85B
Q4'14 2014-12-31 $4.26B
Q3'14 2014-09-30 $3.04B
Q2'14 2014-06-30 $2.99B
Q1'14 2014-03-31 $3.03B
Q4'13 2013-12-31 $2.57B
Q3'13 2013-09-30 $2.01B
Q2'13 2013-06-30 $1.59B
Q1'13 2013-03-31 $1.18B
Q4'12 2012-12-31 $944.5M
Q3'12 2012-09-30 $1.04B
Q2'12 2012-06-30 $893.0M
Q1'12 2012-03-31 $715.0M
Q4'11 2011-12-31 $628.4M
Q3'11 2011-09-30 $810.0M
Q2'11 2011-06-30 $975.6M
Q4'11 2011-03-31
Q2'11 2010-12-31 $847.4M
Q3'11 2010-09-30
Q2'11 2010-06-30
Q2'11 2009-12-31

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (DXCM CIK 0001093557), tagged with the us-gaap and dei taxonomies. The only exception is the live market cap tile, which uses the current share price × shares outstanding from a market quote. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.